Veterinary Dermatology Drugs Market (By Animal Type: Companion Animal, Livestock Animal; By Route of Administration: Oral, Topical, Injectable; By Indication: Parasitic Infections, Allergic Infections, Others; By Distribution Channel: Retail, E-Commerce, Hospital Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary Dermatology Drugs Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary Dermatology Drugs Market, by Animal Type, 2024-2034
8.1.1. Companion Animal
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Livestock Animal
9.1. Veterinary Dermatology Drugs Market, by Route of Administration, 2024-2034
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Topical
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Injectable
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Veterinary Dermatology Drugs Market, by Indication, 2024-2034
10.1.1. Parasitic Infections
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Allergic Infections
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Veterinary Dermatology Drugs Market, by Distribution Channel, 2024-2034
11.1.1. Retail
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. E-Commerce
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Hospital Pharmacies
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.1.3. Market Revenue and Forecast, by Indication (2021-2034)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Indication (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.2.3. Market Revenue and Forecast, by Indication (2021-2034)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Indication (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Indication (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Indication (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.3.3. Market Revenue and Forecast, by Indication (2021-2034)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Indication (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Indication (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Indication (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.4.3. Market Revenue and Forecast, by Indication (2021-2034)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Indication (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Indication (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Indication (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Route of Administration (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Indication (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
13.1. Merial, Zoetis, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Ceva Sante Animale
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Vetmedica
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. IDEXX Laboratories
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Vetoquinol S.A.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Virbac S.A.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bayer Animal Health
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Boehringer Ingelheim
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Elanco
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Novartis Animal Health
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client